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A possible relation between short stature and increased risk of 
mortality and incidence of cardiovascular disease has been 
suggexted for over four decades (l-9). This significant associ- 
ation among men and women was reported recently in two 
large prospective studies-the physicians’ Health Study (10) 
and the Framingham Heart Study (11-d has renewed 
interest in this hypothesis. 
Most previoa irnwtigati011~ have examined the height- 
disease rdathrt in specialized samples, such as male college 
students (2), busmen (3), male civil servants (4), men from 
load cnmnwnities (8). q afe ph@ciims (10). male (1) or female 
hospital patients (7) and elderfy participants (9). We used data 
from the Fmt National Health and Nutrition Fxarnination 
Survey (NHANFS I) Epidcmiologie Foflow-Up Study-a large 
prmpech sludy of the general U.S. populatior+to examine 
the associatkm between height and the risk of four end points: 
incidence of myocardial infarction and coronary heart disease 
(I Am CM Cadid 1996$73678-82) 
and mortality from cardiovascular disease 2nd all other causes. 
Analyses were performed for both standing and sitting height, 
among both men and women and blacks and whites and for 
diaerent age groups (young, middle-aged and elderly). Specitic 
attention was given to removing the confounding effects of aSe 
and socioeconomic status that are related to both height and 
disease end points 
Methods 
Study popdatio~ The NHANES I study (1971 to 1975) 
was designed to collect demographic, m&al history, chnicxl 
and laboratory data on a probability sample of the civilian 
noninstitutionalized population in the United States (12). The 
NHANES 1 Fpiimiologic Follcnv-Up Study was a kmgitudi- 
nal study that comprised a series of follow-up surveys on 14.407 
NHANES 1 respondents (or their proxies) 25 to 74 years old at 
baseline. Follow-up sutveys were conducted from 1932 to 19114 
and again in 1986 (surwying those 255 years old at b&ii) 
and 1987 (13). Parti+mts who were institutionah& after 
baseline were inchrded in the follow-up surveys Ihis report is 
concerned with 11,266 whites and 1,981 blacks (13,247 partic- 
ipants)wbosevitalandmedicathistoriesweresucce&@ 
follnwed up. Onfy 957 subje& (6.7%) were lnst to follow-up, 
and data 00 standiq height were missing in 41 s&jectx 
Complete data on years of education, body weight or systolic 
bkmdprBsurewereiackingforanadditionall75sItl+ta 
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Tab& 1. Number of Events and Subjects at Risk by Gender: First 
Nationdt Heahb and h’utrition Examination Survey Epi&mido@c 
Follow-Up Study, 1971 to 1987 
Ed Points MCtl Women 
lncidcnl cases (fatal or nonfalal) 
MI 
CHD 
Death 
CVD 
Auauscx 
PCmUCSk 
CHD 
Dab 
525 264 
I.ibS I .073 
l&t6 678 
I.701 1243 
4.w 7.w 
5.296 7.735 
~D=caauryhurtdiseax:CVD=ardiwarulv~M1= 
mpardial infaraion. 
Therefore, this analysis included 13,031 persons (4,582 white 
men, 6,528 white women, 714 black men and 1,207 black 
women). For investigation of incidence of myocardial infarc- 
tion and coronary heart disease (fatal and nonfatal events), 
prevalent caxs of coronary heart dii at baseline were 
excluded. Hence, the number of subjects at risk varied for the 
end points studied (Table 1). 
Data eolk!ba Standing height, sitting height and weight 
were measured by spehlly trained examiners with equipment 
that was checked weekly and before each examination at a 
mobile center commenced (14). Height was measured with the 
exam&e wearing dkpasable foam rubber slippers. To mini- 
mize observer and recording errors, height was recorded by a 
Polaroid camera. Weight was measured using a To& self- 
balancing scale that me&a&ally printed the weight to one 
quarter of a pound. Blood pressure was measured by a 
p&ician witb the participant seated. Education level, re- 
corded as the number of years of school completed, and annrral 
family income were used as proxy measures of so&economic 
status Smoking status was classified as “never smoked,” “past 
maker” or “current smoker.” 
Ail swvivo~s and proxy respondents for the &eased 
parkpants were inktiewed in the series of follow-up surveys 
Tbc average follow-up period was I3 years. The occurrences of 
acute myocardii infarction (International Classification of 
D&ases,9thRevis&code410)andooronaryhcartdisease 
(codes 410 to 414 and 429.2) were ascertained from eitkr 
death oertifmxtes or hospital (or nursing home) record. A 
subjeu with any of the aforementioned disease categories was 
dcfrned as an incident ase. Underlying callse5 of death were 
lKedinthei3.ndymofcause-specificmortalitywithaxiea390 
to448 forardiovaseulardisease. . -metbe& Annlyscswerefirstperformedforfnur 
lace-geJ.KkrgroupssepaJa~.&cauxetberesu.hswcrccxm- 
GstentbetweenIktwo~thisreportprcscntsdataby 
genderwithMadtsandwtJitescombiim~rch~ 
baweentwocontinlKluswiaMcswax-witlltbc 
Pcalsoo plxdwt-momeot oomlatioa. ne tax propatioosl 
hazards mak!l (15) w&s UsaI to examiaetheasrocirtioad 
beightandendpointxwitborwithoutadjMingforbaseline 
l’ak 2. Bawline Meautremenrs by Gender 
Men 
(mean * SD vr ‘XI 
- 
Women 
lmcan f SD or sbl 
in. 
Body wghl 
Irp 
lb 
BMI f&n-) 
SBP (mm Hg) 
Fdwatti lyr) 
Family iapmc (Sl.CQlt 
Hitory of diaktn 
Smvbittg stxtra 
kvcr Mokcd 
Pastsmokcr 
Cuncnt tier 
Tl.h I 13.Y 
172 I31 
3.7 : 4. I 
137 z 22 
10.7 2 4.3 
103 2 73 
55 
zL.8 
3.3 
41.Y 
6th z ‘5.0 
167 4 33 
25.7 - c.7 
133 f 16 
I I .c z 3_s 
9.7 z 7.1 
5.5 
56.9 
I I .3 
31.8 
at41 = tmdy mw mkx: SdP = sy?&Ak bbcxi prI?surc. 
age, education level or family income, body mass index, systdic 
blood pressure, smoking status (current or past) and history of 
diabttcs.InfiningtbcCoxmoQlmustdtbcfdlowinotaro 
strategies: 1) Hcigbt was entered into the models s a r~r!in- 
uous variable. Relative risks and their 95% confidence inter- 
vals assnciated with a S-an (-2 in.) &cnz+se in height are 
presented. 2) The distriition of height was grouped into 
gender-specific quintilcs and subjects in the sbortcst beigbt 
category were annpared with those in tbe highest category. 
lttisapproa&wasusedinthcPb+an’sHealtbStudy(lO) 
and I& Framingham Heart Study (11). 
IrJadditiontotcstingtbelinearriELc~tedwithheighl 
tbeporslbilityofaquad&ictrendwasexami&byinchtding 
a quadratic term in the model. The likelibood ratio test was 
usedtoexaminetbe+i6eantdiferenecbe~tbctwo 
models with and wiIbout Ibe quadratic term. In a&lit& 
various fun&d forms of bcigbt were considered, ind* 
log,squareandalbicfonlls. 
AddiM e were perfonoed scpantcly for three 
ageranges:25to39)*prs(pung),~1lo59yurs(middkPgc) 
aad60to74~n(eldcrly).Usingsiningbcightimtcdd 
&Dd.ingbeightiist.bepredictorvariabkorusingfamily 
incomeinsteadofeduutiooastbetbctcyieldalamsi5tent 
reslJl&althougbtlm6edafaareaolrtpoltedberc.- 
sample weighs whkb acatunt for the =* svnpliry 
&signinNHANE!5Ldidnotaltert.bercsults.andonIytbc 
uJ?wcighted results are pfescated here. 
Re!salts 
lladbr--IEemeanv;lhrtsmdpeKuJ~ 
forbaselineage,beigbtandotber&ctedvNiabksaresbown 
inT~2Tbepvc~bright~174rm(685i)ipmw 
and 161 au (635 in.) in tvommTbesekightsrrpcscnfthc 
adultbeigb1oftbcU.s.popubltionduringtbeau!y1971b.Tbe 
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T&k 3. Correlation Coefficients of Height With Selected Variables by Gcndcr’ 
EM1 SBP 
Years of 
Education 
Compk~cd 
Annual 
Famiiy 
Incume 
Mm -032 -0.03 -0.1s c Il.01 0.27 
waml -0.30 -0.13 -U.IY U.U2 (I.?5 
- ..-- .---___ -- 
‘Nl~l&nfocClclcats significanUydi#cr~a~ fromO(p < O.Ol)rxxp~ fur t~~aivrumcholn~rrol(Chol).olherabbr~~tium as in Tablr 2. 
U.23 
U.17 
cut& heights for the 5th. ISth, 85th and 95th percentiles were 
163 cm (64.1 in.), 168 cm (66.1 in.), 181 cm (71.3 in.) and 
186 cm (73.2 in.), respectively, in men and 151 cm (59.4 in.), 
155 em (61.0 in.), 168 cm (66.1 in.) and 172 cm (67.8 in.). 
respectively, in women. 
Table 3 shows the correlation between height and other 
continuous variables. Shorter stature was significantly related 
to unfavorable risk profiles, including older age, greater sys- 
tolic blood pressure and body mass index as well as lower level 
of education and famtiy Income. Serum cholesterol was not 
correlated with height. Current smokers were taller on average 
than never-smokers of either gender (p < 0.05) (data not 
shown). Male and female subjects with a history of diabetes 
were shorter than those without diabetes (data not shown). 
fUskassacbtaiwltlsdcaorPeinheight.Theriskassoci- 
ated with a decrease in height for the selected end points is 
presented in Table 4. These relative risks were calculated using 
height as a continuous variable in a COX model. The relative 
risks were calculated beginning with crude estimates and then 
T&k 4. Risks for S&ted Study End Points Associated With Each 
San (2 in.) Decrease in Height by Gen&r 
RR (95% Cl) 
Adjusmml in MInkI Men wmcn 
lr&tenadMI 
z 
1.16' (1.09-1.23) 1.4l'f1M-1SZ) 
u.98 (0.92-1.0s) l.o9t(I.oo-l.le) 
Aftandcaklcah 0.97 (0.91-1.04) I.05 (O.%-1.14) 
Mllitiwht~ o.Y7 (0.91-1.04) I.04 (0.95413) 
lwickmx d CHD 
Noat 123*(l.u-l.a) 13Y' (1334.46) 
:andc&utiml 
MO (0.93-1.04) 1.06'(1.0L1.11) 
0.98 (0.94~I.03) 1.03 (0.9s1.08) 
M-t 0.98 (0.94-1.03) 1.02 (OS1.07) 
fkatbfromcvD 
E 
1.29'(1.24-1.x) 1.43' (1.3Sl.51) 
1.02 (0974.07) 1.06t(1.00-1.13) 
Age and cd??carim 1.w CO.%-1.06) I.03 (0.97-1.10) 
. . 
-4 0.99 :0.95-1.U4) 1.01 (0.9%1.W) 
Deali&atlcalmzs 
E 
1.26*(l22-I30) L?6'(13U-1.42) 
Ml (0.97-1.04) I.tw (LOU-1.w) 
Agcadcabatim 0.59 (0.9s1.q I.02 (O.%-lrn) 
0.99 (O.%-1.03) IDI (0.5%IM) 
‘p~Q0l.tp~0.05~p~o.lO.SAdjlatmcnlfa~,ycurdebcllim 
Eompkccqw-~qrtdicbbodplwsuTc.auo&ingstatus@ataad 
cami)mdWoryddi&aaRR=nkivc~%%a=%%~ 
~atkra&evi&masiaTa& I. 
after adjustment for age alone, age and education and all other 
covariates in the model. Initially, in the crude analysis, each 
5-cm (2 in.) decrease in height was associated with a 16% and 
41% increased risk of incidence of myocardial infarction in 
men and women, respcctive:y. When age was added to the 
model, the risk was sizably reduced and only modestly different 
from 1.0 in women (p = 0.055). After further adjustment for 
level of education, a significant relation between height and 
myocardial infarction no longer existed. Similar patterns were 
observed for incidence of coronary heart disease, death from 
cardiovascular disease and all causes of death (Table 4). 
Additional anafyses. To further examine whether the ex- 
cess risk was restricted to subjects with the shortest stature, 
anafyses were performed comparing persons in the lowest 
height quintile with those in the highest quintike. Although the 
shortest subjects, in general. had a significantly greater risk 
compared with the tallest, no excess risk was found when the 
effects of age and education were considered. 
Because the relation between height and studied end points 
might not be strictfy linear, various functional forms of height 
were explored ix predicting risk, including a quadratic term, 
log, square and cubic transformations. There was no evidence 
of an association between various forms of height with end 
points in multivariate-adjusted models. 
Ibe resuits were not significantly altered when analyses 
were performed separately for persons 25 to 39,40 to 59 and 
60 to 74 years old or when sitting height was used rather than 
standing height and family income instead of education. 
Discussion 
Data from this prospective cohort study in a national 
sample do not support the hypothesis that shon stature is 
independently associated with an excess risk of various disease 
end points, including incidence of myocardial infarction, cor- 
onary heart disease, overall mortality aud mortality from 
cardiovascular dii. These findings are consistent for men 
and women; blacks and whites; young, middle-aged and el- 
derly. Any observed univariate trend of inverse association 
between height and morbiity or mortality was mostly due to a 
confounding relation of height with age and socioeconomic 
status. 
Agcspd~statma. ItisnotsurpriQngthatage 
is the most important confounder munting for the height- 
disease relation. In this study, the mean age of the shortest 
height quintik was 14 years older than the tallest height 
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quintile among men and 13 years older among women. The 
inverse relation between age and height can be explained by a 
secula: trend of increasig hcigi~t in the population (16). as 
well as by the presence of height loss associahed with aging 
(17). Social and environmental factors are astiated with 
height in childhood (IS) and adulthood (19). Among men and 
women of this cohort, the mean education level was 3.4 years 
and 2.4 years lower, respectively, comparing the shortest l-eight 
quintile to the tallest quintile. There was a~ a 3% and 31% 
lower family inmme for men and women, rcspcctively, in the 
shortest category. Some reports (3,X)) have also found that 
socioeamnmic status is a potential confounder in the height- 
disease relation. 
PrAaus reports. Although in the most published reports 
there appears to be an inverse relation between height and 
morbidity or mortality (1,2,4-l I), the evidence is not mnsis- 
tent. Early reports did not perform multivariate analyses 
(1.25) or test for significant differences (6). Some studies were 
case-control in nature (127). Self-reported height was used in 
many studies (6,7,9,10), including the Phpicians’ Health Study 
(10). Investigations of patients (1,7) or subjects from specific 
occupational groups, such as college students (2). busmen (3), 
civil servants (4) or p!.. Gins (lo), were more mmmon than 
tbosc in general population samples (S.&l I). Although some 
studies have adjusted for occupational class (4.68). other 
dimensions of socioeconomic status, such as education and 
income. which were not interchangeable with mpation (21). 
were not measured. In some other studies (5.1 I). including the 
Framingbarn Study (I I), investigators were not able lo adjust 
for the potential confounding of socioeconomic status and 
height. Many reports focuseci on men only (l-4,8,10). Recent 
studies of both genders have rbund the relation between height 
and cardiovascular disease in women but not in men (9.11). 
Furthermore, among the prospective studies that reported 
multiple end points (4,6,9-l 1). height was often related to a 
single end point (10.11) or to two end points (9). 
Given that the current study was based on a m~~ltisraged 
probability saznple intended to provide the basis for inference 
to the U.S. population, less selection bias and greater gener- 
alization wouA be expected than in most previous studies 
conducted in occupational settings or restricted demographic 
or geographic areas. &cause we had an ample number of 
participants. we were able to study the heigbt-disease hypoth- 
esis in all major race, gender and age groups for multiple end 
points. Another strength of this study was its longer follow-up 
(average of 13 years) compared with that of many other 
mhorrs (4.6,8-10) whose follow-up durations were mostly 3 to 
6 yean. 
Mcelunisms lqpddnd prwiady. Several bidogicdly 
plausitk mechanisms have ken suggested to explain the 
invcne relation of height to risk of disease, but none are 
convincing. Height may be a marker for lumen diameter of tbe 
mronary artery and thus link height IO hat disease (7.9-I 1). 
However. dir& rneasunments did not show a mrrebtion 
between height and caliber of the mid-left anterior Ming 
artery (spearman’s miatioh 0.092) (10). Hii operative 
mortality among women than men from coronary artery bypass 
graft surgery has been attributed to smaller physical size and 
thus narrower coronary arteries in women (22). However. 
beyond the periopcrative period, there appears IO be no 
difference in long-term survival between male and female 
patients (22-24). A recent study (25) showed t!!e! short stature 
was a :A factor for in-hospital but not long-term mortality 
amonk patients after angioplaty. Although studies have found 
higher mortality in women than in men after a rnyccardial 
infarction (26-28), thcx differences were mostly related to 
age. risk factor profile and severiry of preexisting coronary 
disease (29-31). Moreover, the relation between lumen diam- 
cter of the coronary arteries and the incidence or mortality 
from hean disease has not yet been established within genders. 
Researchers also hypothesize that early growth factors. which 
may be correlated with adult height. or hemostatic mechanisms 
may have a role in the height-disease relation (9.10). because 
there is evidence that fetal and infant undernutrition incra 
the risk of mronary disease in adulthood (32). Unfavorable 
hemostatic status was correlated with reduced growth in fetal 
life and infancy on the one hand (33) and independently 
associated with increased rates of coronary disease on the 
other (34). However, no direct data have demonstrated that 
short stature, either in cbildbood or adulthood. IS related to 
hemostatic risk independent of lmdy weight or body mass 
in&x. 
Some researchers have suggrued that the height-disease 
relation may be explained by differences in lung function 
(35,.X). However. mnllicting findings have been reported 
(8,9). Of the NHANELS I participants. 50% performed a lung 
function test. Acceptable forced expiratory spirog-ams were 
obtained in 5.079 particip0nts (39%) (231 men and 2778 
women). When any one indicator of lung function (e.g., forced 
vital capacity, forced expiratofy volume in I s or peak expira- 
tory flow rate [either maximal or residual valueJ) was co1uid- 
ered together with height and age in the Cox model. lung 
function, but not height, was a predictor for all of the studied 
end points (data not shown). The results were similar when 
analyses were limited to those who had never smoked. 
possibk m l-be limitaiions of the present study 
include a possible bias arising from a last to follow-up status. 
The NHANES I E+Gimiologic Folluw-Up Study obtained a 
satisfactory tracing rate for vital status (95.8%) (13). Tbere 
should be relatively little bias in mortality and morbidity 
find@ as a result of lost to fdbw-up status. The mean height 
(174 cm 1685 in-J) of men in this study sample was bwer than 
ihat reported in the Physicians’ Health Study (178 CIII 
[to.1 in. J) (10). In the Ph@ciarrs’ Health Study. self-reported 
height was categorized. Seventeen percent of male pb@ans 
were 185 cm (73 in.) w railer. whereas only 5% of tbc men in 
the present shdy were this tall. To preclude a possible 
advantageofbcingverytallorapsibkdkadvantageofbeing 
very short, we mmpared mea in tlu top 5% of height with 
those1170cm(167in.,thclurwcstbcightQte~uudiothe 
~HeahhSttdy)acdwitbtboaeintbebortcm15%d 
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tbc distribution. No sign&cant association was found between 
being wry tall or very shon and the disease end points. 
m The results of this epidemiologic study pro- 
vide no evidence qporting the height-heart disease hypth- 
esk Althg,h the majority of studies in the published reports 
propcs the short stature paradigm of heart discax, careful 
examination of these studies demonstrates weaknesses and 
ina~misteneie~ CkarIy, this issue must be further examined in 
many shtdies before any Beoeral conclusions can be drawn and 
recommendations made. 
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